litlas
ログインアカウント作成

Bella Kaufman

1983–2022 年に発表

97
論文数
33,054
被引用数
77
h 指数
97
i10 指数

被引用数

Bella Kaufman の年別被引用数1971 年: 被引用 1 件1985 年: 被引用 3 件1986 年: 被引用 2 件1987 年: 被引用 8 件1988 年: 被引用 7 件1989 年: 被引用 3 件1990 年: 被引用 7 件1991 年: 被引用 15 件1992 年: 被引用 14 件1993 年: 被引用 15 件1994 年: 被引用 9 件1995 年: 被引用 6 件1996 年: 被引用 7 件1997 年: 被引用 10 件1998 年: 被引用 20 件1999 年: 被引用 24 件2000 年: 被引用 28 件2001 年: 被引用 25 件2002 年: 被引用 32 件2003 年: 被引用 40 件2004 年: 被引用 34 件2005 年: 被引用 32 件2006 年: 被引用 32 件2007 年: 被引用 75 件2008 年: 被引用 122 件2009 年: 被引用 138 件2010 年: 被引用 175 件2011 年: 被引用 177 件2012 年: 被引用 166 件2013 年: 被引用 189 件2014 年: 被引用 182 件2015 年: 被引用 214 件2016 年: 被引用 254 件2017 年: 被引用 240 件2018 年: 被引用 257 件2019 年: 被引用 821 件2020 年: 被引用 1,273 件2021 年: 被引用 1,547 件2022 年: 被引用 1,317 件2023 年: 被引用 1,120 件2024 年: 被引用 1,476 件2025 年: 被引用 750 件2026 年: 被引用 32 件1972〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,502 件、この内訳の 21.9%中国: 引用元論文 1,624 件、この内訳の 10.1%イタリア: 引用元論文 979 件、この内訳の 6.1%イギリス: 引用元論文 977 件、この内訳の 6.1%ドイツ: 引用元論文 733 件、この内訳の 4.6%フランス: 引用元論文 712 件、この内訳の 4.4%スペイン: 引用元論文 591 件、この内訳の 3.7%カナダ: 引用元論文 581 件、この内訳の 3.6%オーストラリア: 引用元論文 447 件、この内訳の 2.8%ベルギー: 引用元論文 421 件、この内訳の 2.6%日本: 引用元論文 365 件、この内訳の 2.3%スイス: 引用元論文 360 件、この内訳の 2.3%
0%21.9%その他 29.5%

機関

分野

  • Medicine59%
  • Biochemistry, Genetics and Molecular Biology33.8%
  • Immunology and Microbiology2.3%
  • Engineering1%
  • Computer Science0.7%
  • Materials Science0.6%
  • その他2.6%

トピック

  • Advanced Breast Cancer Therapies5.7%
  • HER2/EGFR in Cancer Research5.5%
  • PARP inhibition in cancer therapy4.4%
  • Breast Cancer Treatment Studies4.4%
  • BRCA gene mutations in cancer3.2%
  • Cancer Genomics and Diagnostics3.1%
  • その他73.7%

共著者

全論文

検索で開く
  1. The human tumor microbiome is composed of tumor type–specific intracellular bacteria

    著者: Deborah Nejman, Ilana Livyatan, Garold Fuks, Nancy Gavert, Yaara Zwang, Leore T. Geller, Aviva Rotter-Maskowitz, Roi Weiser, Giuseppe Mallel, Elinor Gigi, Arnon Meltser, Gavin M. Douglas, Iris Kamer, Vancheswaran Gopalakrishnan, Tali Dadosh, Smadar Levin‐Zaidman, Sofia Avnet, Tehila Atlan, Zachary A. Cooper, Reetakshi Arora, Alexandria P. Cogdill, Md Abdul Wadud Khan, Gabriel O Ologun, Yuval Bussi, Adina Weinberger, Maya Lotan‐Pompan, Ofra Golani, Gili Perry, Merav Rokah, Keren Bahar‐Shany, Elisa A. Rozeman, Christian U. Blank, Anat Ronai, Ron Shaoul, Amnon Amit, Tatiana Dorfman, Ran Kremer, Zvi R. Cohen, Sagi Harnof, Tali Siegal, Einav Yehuda‐Shnaidman, Einav Nili Gal‐Yam, Hagit Shapira, Nicola Baldini, Morgan G. I. Langille, Alon Ben‐Nun, Bella Kaufman, Aviram Nissan, Talia Golan, Maya Dadiani, Keren Levanon, Jair Bar, Shlomit Yust‐Katz, Iris Barshack, Daniel S. Peeper, Dan J. Raz, Eran Segal, Jennifer A. Wargo, Judith Sandbank, Noam Shental, Ravid Straussman - Science 2020 被引用: 2,471

  2. Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer

    著者: Fabrice André, Eva Ciruelos, Gábor Rubovszky, Mario Campone, Sibylle Loibl, Hope S. Rugo, Hiroji Iwata, PierFranco Conte, Ingrid A. Mayer, Bella Kaufman, Toshinari Yamashita, Yen‐Shen Lu, Kenichi Inoue, Masato Takahashi, Zsuzsanna Pápai, Anne-Sophie Longin, David Mills, Celine Wilke, Samit Hirawat, Dejan Juric - New England Journal of Medicine 2019 被引用: 2,572

  3. Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer

    著者: Andrew Tutt, Judy E. Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli, Priya Rastogi, Richard D. Gelber, Evandro de Azambuja, Anitra Fielding, Judith Balmaña, Susan M. Domchek, Karen A. Gelmon, Simon J. Hollingsworth, Larissa A. Korde, Barbro Linderholm, Hanna Bandos, Elżbieta Senkus, Jennifer M. Suga, Zhimin Shao, Andrew W. Pippas, Zbigniew Nowecki, Tomasz Huzarski, Patricia A. Ganz, Peter C. Lucas, Nigel Baker, Sibylle Loibl, Robin McConnell, Martine Piccart, Rita K. Schmutzler, Guenther G. Steger, Joseph P. Costantino, Amal Arahmani, Norman Wolmark, Eleanor McFadden, Vassiliki Karantza, Sunil R. Lakhani, Greg Yothers, Christine Campbell, Charles E. Geyer - New England Journal of Medicine 2021 被引用: 1,665

  4. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

    著者: Fátima Cardoso, Shani Paluch–Shimon, Elżbieta Senkus, Giuseppe Curigliano, Matti Aapro, Fabrice André, C.H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Frances Boyle, Maria João Cardoso, L.A. Carey, Javier Cortés, Nagi S. El Saghir, Mona Elzayat, Alexandru Eniu, Lesley Fallowfield, Prudence A. Francis, Karen A. Gelmon, Joseph Gligorov, Renate Haidinger, Nadia Harbeck, Xin Hu, Bella Kaufman, Rajneesh Kaur, Belinda E. Kiely, S.-B. Kim, NU Lin, Shirley Mertz, Silvia P. Neciosup, B.V. Offersen, Shinji Ohno, Olivia Pagani, A. Prat, Frédérique Penault‐Llorca, Hope S. Rugo, G. W. Sledge, Christoph Thomssen, D.A. Vorobiof, Theresa Wiseman, Binghe Xu, Larry Norton, A. Costa, Eric P. Winer - Annals of Oncology 2020 被引用: 1,356

  5. 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

    著者: Fátima Cardoso, A. Costa, Elżbieta Senkus, Matti Aapro, Fabrice André, Carlos H. Barrios, Jonas Bergh, G.S. Bhattacharyya, Laura Biganzoli, Maria João Cardoso, L. Carey, D. Corneliussen-James, Giuseppe Curigliano, Véronique Dièras, N. El Saghir, Alexandru Eniu, Lesley Fallowfield, D. Fenech, Prudence A. Francis, Karen A. Gelmon, Alessandra Gennari, Nadia Harbeck, Clifford A. Hudis, Bella Kaufman, Ian E. Krop, Musa Mayer, Hanneke Meijer, Shirley Mertz, Shinji Ohno, Olivia Pagani, Efthymios Papadopoulos, Fedro A. Peccatori, Frédérique Penault‐Llorca, Martine Piccart, Jean‐Yves Pierga, Hope S. Rugo, Lillie D. Shockney, George W. Sledge, Sandra M. Swain, Christoph Thomssen, Andrew Tutt, Daniel Vorobiof, Binghe Xu, Larry Norton, Eric P. Winer - Annals of Oncology 2016 被引用: 2,062

  6. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    著者: Charles E. Geyer, Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross, Priya Rastogi, Karen Cui, Amal Arahmani, Gursel Aktan, Anne Armstrong, Mónica Arnedos, Judith Balmaña, Jonas Bergh, Judith M. Bliss, Suzette Delaloge, Susan M. Domchek, Andrea Eisen, F. Elsafy, L.E. Fein, Anitra Fielding, James M. Ford, Sue Friedman, Karen A. Gelmon, Luca Gianni, Michael Gnant, Simon J. Hollingsworth, Seock‐Ah Im, Agnes Jager, Oskar T. Johannsson, Sunil R. Lakhani, W Janni, Barbro Linderholm, T.-W. Liu, Niklas Loman, Larissa A. Korde, Sibylle Loibl, Peter C. Lucas, Frederik Marmé, E. Martinez de Dueñas, Robin McConnell, Kelly‐Anne Phillips, Martine Piccart, Giovanna Rossi, Rita K. Schmutzler, Elżbieta Senkus, Zhi-Ming Shao, Priyanka Sharma, Christian F. Singer, Tanja Španić, Elmar Stickeler, Masakazu Toi, Tiffany A. Traina, Giuseppe Viale, Gabriele Zoppoli, Y.H. Park, Rinat Yerushalmi, Huan Yang, D. Pang, Kyung Hae Jung, Audrey Mailliez, Zhaoqing Fan, Isabelle Tennevet, J. Zhang, T. Nagy, Gabe S. Sonke, Qiuhong Sun, Marina Parton, Marco Colleoni, Marcus Schmidt, Adam Brufsky, W. Razaq, Bella Kaufman, David Cameron, Christine Campbell, Andrew Tutt, P. Sevelda, Ferdinand Haslbauer, Monika Penzinger, Leopold Öhler, Christoph Tinchon, Richard Greil, Sonja Heibl, Rupert Bartsch, Viktor Wette, Christian F. Singer, Claudia Pasterk, Ruth Helfgott, Gunda Pristauz-Telsnigg, Herbert Stöger, A. Weltermann, Daniel Egle, I. Thiel, David Fuchs, Holger Rumpold, Kathrin Strasser‐Weippl, Beate Rautenberg, Volkmar Müller, Marcus Schmidt, Stefan Paepke ほか 509 名 - Annals of Oncology 2022 被引用: 447

  7. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

    著者: Fabrice André, Eva Ciruelos, Dejan Juric, Sibylle Loibl, Mario Campone, Ingrid A. Mayer, Gábor Rubovszky, Toshinari Yamashita, Bella Kaufman, Yen‐Shen Lu, Kenichi Inoue, Zsuzsanna Pápai, Masato Takahashi, Farhat Ghaznawi, David Mills, Mathilde Kaper, Michelle C. Miller, PierFranco Conte, Hiroji Iwata, Hope S. Rugo - Annals of Oncology 2020 被引用: 599

  8. Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study

    著者: Susan M. Domchek, Sophie Postel‐Vinay, Seock‐Ah Im, Yeon Hee Park, Jean‐Pierre Delord, Antoîne Italiano, Jérôme Alexandre, Benoît You, Sara Bastian, Matthew Krebs, Ding Wang, Saiama N. Waqar, Mark C. Lanasa, Joon Haeng Rhee, Haiyan Gao, Vidalba Rocher-Ros, Emma V. Jones, Sakshi Gulati, Anna Coenen-Stass, Iwanka Kozarewa, Zhongwu Lai, Helen K. Angell, Laura Opincar, Pia Herbolsheimer, Bella Kaufman - The Lancet Oncology 2020 被引用: 459

  9. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

    著者: Charles E. Geyer, John Forster, Deborah Lindquist, Stephen Chan, C. Gilles Romieu, Tadeusz Pieńkowski, Agnieszka Jagiełło-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark S. Berger, Cristina Oliva, Stephen D. Rubin, Steven Stein, David Cameron - New England Journal of Medicine 2006 被引用: 3,461

  10. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

    著者: Bella Kaufman, Ronnie Shapira‐Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedländer, Judith Balmañà, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Mariana Steiner, Niklas Loman, Karin Bowen, Anitra Fielding, Susan M. Domchek - Journal of Clinical Oncology 2014 被引用: 1,678

  11. Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

    著者: Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso, Javier Cortés, Giuseppe Curigliano, Antonino Musolino, Mark D. Pegram, Gail S. Wright, Cristina Saura, Santiago Escrivá-de-Romaní, Michelino De Laurentiis, Christelle Lévy, Ursa Brown‐Glaberman, Jean-­Marc Ferrero, Maaike de Boer, Sung‐Bae Kim, Katarína Petráková, Denise A. Yardley, Orit Freedman, Erik Jakobsen, Bella Kaufman, Rinat Yerushalmi, Peter A. Fasching, Jeffrey L. Nordstrom, Ezio Bonvini, Scott Koenig, Sutton Edlich, Shengyan Hong, Edwin P. Rock, William J. Gradishar, SOPHIA Study Group - JAMA Oncology 2021 被引用: 349

  12. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

    著者: Fátima Cardoso, Elżbieta Senkus, A. Costa, Efthymios Papadopoulos, Matti Aapro, Fabrice André, Nadia Harbeck, B. Aguilar Lopez, C.H. Barrios, Jonas Bergh, Laura Biganzoli, C.B. Boers-Doets, Maria João Cardoso, L.A. Carey, Javier Cortés, Giuseppe Curigliano, Véronique Dièras, Nagi S. El Saghir, Alexandru Eniu, Lesley Fallowfield, P.A. Francis, Karen A. Gelmon, S. Johnston, Bella Kaufman, Smruti Koppikar, I.E. Krop, Musa Mayer, Gertrude Nakigudde, B.V. Offersen, Shinji Ohno, Olivia Pagani, Shani Paluch–Shimon, Frédérique Penault‐Llorca, Aleix Prat, H.S. Rugo, G. W. Sledge, Danielle Spence, Christoph Thomssen, D.A. Vorobiof, B. Xu, Larry Norton, E.P. Winer - Annals of Oncology 2018 被引用: 1,190

  13. ESO–ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)

    著者: Shani Paluch–Shimon, Fátima Cardoso, Ann H. Partridge, Omalkhair Abulkhair, Hatem A. Azim, G. Bianchi-Micheli, Maria João Cardoso, Giuseppe Curigliano, Karen A. Gelmon, Oreste ­Gentilini, Nadia Harbeck, Bella Kaufman, S.B. Kim, Q. Liu, J. Merschdorf, Philip Poortmans, Giancarlo Pruneri, Elżbieta Senkus, Bhawna Sirohi, Tanja Španič, Virpi Sulosaari, Fedro A. Peccatori, Olivia Pagani - Annals of Oncology 2022 被引用: 218

  14. Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Véronique Dièras, Hyo S. Han, Bella Kaufman, Hans Wildiers, Michael Friedländer, Jean-Pierre Ayoub, Shannon L. Puhalla, Igor Bondarenko, Mario Campone, Erik Jakobsen, Mathilde Jalving, Cristina Oprean, Markéta Palácová, Yeon Hee Park, Yaroslav Shparyk, Eduardo Yáñez, Nikhil Khandelwal, Madan G. Kundu, Matthew W. Dudley, Christine K. Ratajczak, David Maag, Banu Arun - The Lancet Oncology 2020 被引用: 321

  15. Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE

    著者: Eleftherios P. Mamounas, Michael Untch, Max S. Mano, Chiun‐Sheng Huang, Charles E. Geyer, Gϋnter von Minckwitz, Norman Wolmark, Xavier Pivot, Sherko Küemmel, Michael P. DiGiovanna, Bella Kaufman, Georg Kunz, Alison Conlin, Juan Carlos Alcedo, Thorsten Kuehn, Irene Wapnir, Andrea Fontana, John Hackmann, Jonathan Polikoff, Mahasti Saghatchian, Adam Brufsky, Youngsen Yang, Martina Zimovjanová, Thomas Boulet, H. Liu, David Tesarowski, Lisa H. Lam, Chunyan Song, Melanie C. Smitt, Sibylle Loibl - Annals of Oncology 2021 被引用: 123

  16. Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

    著者: Bella Kaufman, John R. Mackey, Michael Clemens, P. P. Bapsy, Ashok K. Vaid, Andrew Wardley, Sergei Tjulandin, Michaela K. Jahn, Michaela Lehle, A. Feyereislova, Cédric Révil, Alison Jones - Journal of Clinical Oncology 2009 被引用: 850

  17. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells

    著者: Hagai Ligumsky, Ido Wolf, Shira Israeli, Michal Haimsohn, Sarah Ferber, Avraham Karasik, Bella Kaufman, Tamar Rubinek - Breast Cancer Research and Treatment 2011 被引用: 108

  18. Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

    著者: David Miles, Eva Ciruelos, A. Schneeweiss, Fabio Puglisi, Tamar Peretz‐Yablonski, Mario Campone, Igor Bondarenko, Zbigniew Nowecki, Hassan Errihani, Shani Paluch–Shimon, A. Wardley, Jean-Louis Merot, Peter C. Trask, Yolande Du Toit, Claudia Peña-Murillo, Valentine Revelant, Dirk Klingbiel, T. Bachelot, T. Bachelot, K. Bouzid, Mario Campone, Isabelle Desmoulins, Bruno Coudert, Igor Bondarenko, Zbigniew Nowecki, I. Głogowska, Eva Ciruelos Gil, Hassan Errihani, Florence Dalenc, Francesco Ricci, Véronique Dièras, Bella Kaufman, Shani Paluch–Shimon, A. Wardley, A. Schneeweiss, Ana Filipa Ferreira, Max S. Mano, Haralabos P. Kalofonos, Claudia Andreetta, F. Puglisi, Filippo Montemurro, Sophie Barrett, Q. Zhang, Dimitriοs Mavroudis, Juan Antonio Matus, C. Villarreal Garza, C. Beato, Gustavo Ismael, Xiaoyu Hu, Hamdy Abdel Azeem, Rabab Gaafar, Christophe Perrin, Pierre Kerbrat, Johannes Ettl, Stefan Paepke, Erika Hitre, István Láng, Marc Trudeau, Sunil Verma, H. Li, Oliver Hoffmann, Bahriye Aktas, Anna Cariello, G. Cruciani, A. Tienghi, Carlo Tondini, T. Al-Twegieri, Niklas Loman, Robert Laing, David Miles, Étienne Brain, Peter A. Fasching, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, J. Fernando Salas, Joanna Streb, K. Krzemieniecki, A Wroński, J. García García, Salomón Menjón Beltrán, I. Cicin, Peter Schmid, Chris Gallagher, Nicholas C. Turner, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Zsolt Horváth, Giampaolo Bianchini, Luca Gianni, Giuseppe Curigliano, Alejandro Juárez Ramiro, Sneẑana Šušnjar, Eduarda Matos, Elena Sevillano, L. Garcia Estevez, Erhan Gökmen, Rüçhan Uslu, Hans Wildiers ほか 283 名 - Annals of Oncology 2021 被引用: 89

  19. Randomized Phase II Study of the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer

    著者: José Baselga, Patricia Gómez, Richard Greil, Sofía Braga, Miguel Ángel Climent, Andrew Wardley, Bella Kaufman, Salomon M. Stemmer, António Pêgo, Arlene Chan, J. Goeminne, Marie-Pascale Graas, Megan Kennedy, Eva María Ciruelos Gil, Andreas Schneeweiß, Angela Zubel, Jutta Groos, Helena Melezínková, Ahmad Awada - Journal of Clinical Oncology 2013 被引用: 351

  20. Efficacy and safety of olaparib monotherapy in germline BRCA1 / 2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy

    著者: Susan M. Domchek, Carol Aghajanian, Ronnie Shapira‐Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedländer, Judith Balmañà, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Niklas Loman, Jane Robertson, Helen Mann, Bella Kaufman - Gynecologic Oncology 2015 被引用: 300

  21. ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

    著者: Adi Zundelevich, Maya Dadiani, Smadar Kahana‐Edwin, Amit Itay, Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, Anya Pavlovski, Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam - Breast Cancer Research 2020 被引用: 118

  22. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2

    著者: Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun‐Cohen, Karen Djemal, Jessica B. Mandell, Ming K. Lee, Uziel Beller, Raphael Catane, Mary‐Claire King, Ephrat Levy‐Lahad - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 345

  23. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury

    著者: Dror Meirow, Dor J, Bella Kaufman, Alon Shrim, Jaron Rabinovici, E. Schiff, Hila Raanani, Jacob Levron, Eddie Fridman - Human Reproduction 2007 被引用: 337

  24. Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis

    著者: Adi Zundelevich, Maya Dadiani, Smadar Kahana‐Edwin, Amit Itay, Tal Sella, Moran Gadot, Karen Cesarkas, Sarit Farage-Barhom, Efrat G. Saar, Eran Eyal, Nitzan Kol, Anya Pavlovski, Nora Balint‐Lahat, Daniela Dick‐Necula, Iris Barshack, Bella Kaufman, Einav Nili Gal‐Yam - Breast Cancer Research 2020 被引用: 64